TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

SHAREHOLDER ALERT: DiCello Levitt LLP Announces That A Shareholder Class Action Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Dicello Levitt Llp
SHAREHOLDER ALERT: DiCello Levitt LLP Announces That A Shareholder Class Action Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

DiCello Levitt LLP filed a class action lawsuit against MoonLake Immunotherapeutics, alleging false statements about their drug candidate sonelokimab's efficacy. The lawsuit covers stock purchases between March 10, 2024, and September 29, 2025, following a significant stock price drop after Phase 3 trial results.

Insights
NVDA   positive

Mentioned as predicting $3-4 trillion in data center infrastructure spending by 2030, indicating strong market potential


MLTX   negative

Stock price dropped 89.9% after Phase 3 trial results showed drug candidate failed to demonstrate competitive efficacy, and a class action lawsuit was filed alleging misleading statements about the drug's potential